Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Cash from Investing Activities (2018 - 2025)

BioNexus Gene Lab's Cash from Investing Activities history spans 8 years, with the latest figure at -$5717.0 for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$5717.0 for Q4 2025, down 101.03% from a year ago — trailing twelve months through Dec 2025 was $944751.0 (up 125.91% YoY), and the annual figure for FY2025 was $944751.0, up 125.91%.
  • Cash from Investing Activities for Q4 2025 was -$5717.0 at BioNexus Gene Lab, down from $994646.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $994646.0 in Q3 2025 to a low of -$1.4 million in Q4 2023.
  • The 5-year median for Cash from Investing Activities is -$39217.5 (2022), against an average of -$68616.0.
  • The sharpest move saw Cash from Investing Activities plummeted 2756.3% in 2023, then skyrocketed 2170.31% in 2024.
  • Year by year, Cash from Investing Activities stood at -$76289.0 in 2021, then soared by 34.59% to -$49903.0 in 2022, then plummeted by 2756.3% to -$1.4 million in 2023, then skyrocketed by 138.9% to $554402.0 in 2024, then plummeted by 101.03% to -$5717.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$5717.0, $994646.0, and -$28532.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.